Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibromatoses 1Neoplasm Metastasis 1Melanoma 1Cutaneous Metastases 1

Interventions

Deoxycholic Acid 4AZD 6244 4Polidocanol 2Lasers, Solid-State 2talimogene laherparepvec 1pomalidomide 1pirfenidone 1lorlatinib 1encorafenib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1X-Rays 1Vinblastine 1Specimen Handling 1Sorafenib 1Photons 1Pharmacokinetics 1Magnetic Resonance Spectroscopy 1Lovastatin 1Lasers 1Imiquimod 1High-Energy Shock Waves 1Curcumin 1Cetuximab 1Carboplatin 1Biopsy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibromatosis 1 × diphenylcyclopropenone × Clear all
NCT05438290 2024-05-06

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
17 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡